secwatch.observer — SEC 8-K summary
======================================

Issuer:     Olema Pharmaceuticals, Inc. (OLMA)
CIK:        0001750284
Form:       8-K
Filed at:   2025-11-18T23:59:59+00:00
Accession:  0001193125-25-286206
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Olema terminates ATM prospectus; no further sales until new filing
------------------------------------------------------------------

- Terminated ATM prospectus effective November 18, 2025.
- Sales Agreement with TD Securities dated January 6, 2025 remains in force.
- No further sales of common stock under the ATM until new prospectus filed.
- Olema had not disclosed any sales under the prior ATM; no amounts given.
- Move may indicate intent to file updated prospectus or reduce equity dilution.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1750284/000119312525286206/0001193125-25-286206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1750284/000119312525286206/d86905d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-286206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer